Hepatology
Signal score, how each part rates
ActionabilityPrevalenceStakesEvidence strengthNovelty
See the full rubric →Review Article: Cancer Surveillance for Early Detection of Liver Cancer in Patients with HBV Infection.
Clinical takeawayFollow guideline-defined risk criteria for HCC surveillance in HBV-infected patients: perform ultrasound with or without AFP every 6 months for those meeting surveillance criteria, and reassess risk periodically for those with an annual HCC risk below 0.2%. Emerging biomarker, imaging, and artificial-intelligence approaches remain adjunctive or investigational pending further HBV-specific validation.
What it foundPatients with HBV infection and an estimated annual HCC risk below 0.2% do not require routine surveillance, while guideline-eligible patients should undergo ultrasound with or without AFP every 6 months. Guideline-defined risk criteria include specific thresholds and factors not detailed here.
ContextConfirms current practice of risk-stratified HCC surveillance in HBV infection, emphasizing adherence to guideline-defined criteria and periodic risk reassessment. Emerging approaches are not yet validated for routine use.
No standard claimed for this paper
Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.
Park AJ … Pan CQ · Alimentary Pharmacology & Therapeutics · IF 6.7 · PubMed ↗